| |
INSTI & Diabetes Risk - 3 studies
|
| |
| |
Download the PDF here
Download the PDF here
Download the PDF here
Download the PDF here
A North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) study identified RAL as a strong predictor of DM but found no association between DM and overall INSTI drug class when adjusted for weight gain after 1 year on INSTIs.
Similarly, the Dat’AIDS French cohort study found no association between INSTI use and DM after adjusting for BMI.
In RESPOND, compared with non-INSTIs, current use of INSTIs was associated with an increased DM risk, which partially attenuated when adjusted for BMI changes and other variables.
|
|
| |
| |
|
|
|
